Clinical Trials Browser

Phase 2 × Carcinoma × apatinib × Clear all

NCT05265793 2022-03-04

Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma

Phase 2 Unknown

Carcinoma, Carcinosarcoma